Moneycontrol PRO
HomeNewsIndiaCBI special court reserves S Eswara's bail application in bribery case

CBI special court reserves S Eswara's bail application in bribery case

The CBI counsel today requested the special court for voice sampling of all the five accused.

July 15, 2022 / 16:13 IST

The special Central Bureau of Investigation (CBI) court today reserved the order on the bail application of four accused -  Joint Drugs Controller S Eshwara Reddy, Dinesh Dua, L Praveen Kumar, and Guljit Sethi in an alleged bribery case has been reserved by the special court or July 18.

The bail plea of another accused Animesh Kumar will be heard tomorrow.

Meanwhile, the CBI counsel also requested the special court for the voice sampling of all the five accused.

As per the sources, said the word 'data' used in trial application was allegedly replaced by 'protocol', which may have benefitted the company for getting the approval of drug.

"On the basis of communications and interceptions of the calls of the accused, it was found that they were indulging in wrong doings. That's why the CBI has demanded their voice sample," the official said.
The voice sampling application of all five accused had been filed in June 21 before the vacation bench and was pending.

Also Read: CBI arrests joint drugs controller S Eswara Reddy in bribery case to clear Biocon Biologics injection

Last month, the CBI had arrested S Eswara Reddy for allegedly receiving a Rs 4 lakh bribe to waive the phase three clinical trial of the Insulin Aspart injection, a product of Biocon Biologics under development to manage Type 1 and Type 2 diabetes.

Biocon Biologics, a subsidiary of Biocon has denied all the allegations of bribery.

The agency had also arrested Dinesh Dua, director at Synergy Network India Private Limited, who was allegedly giving Reddy a bribe. After completing the necessary paperwork, the CBI arrested Reddy and Dua, nabbed during a trap operation while the alleged bribe exchange was going on.

Ayushman Kumar
Ayushman Kumar Covers health and pharma for MoneyControl.
first published: Jul 15, 2022 02:08 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347